The authors also argued that FBLN1 can influence the transforming growth factor-β (TGF-β) pathway to regulate EMT [19], which was verified as the vital role in cardiovascular cells and in many cardiovascular diseases, such as hypertension, cardiac hypertrophy, atherosclerosis and restenosis [32–34]. Here, TGFB1 is linked to cardiovascular disorder.